Fig. 2From: Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer seriesSeparate centroid correlation when NanoString nCounter® and RNA-Seq platforms are compared. The blue line represents the linear regression. The grey area surrounding it represents the confidence intervalBack to article page